Biotech China 2014

View Profile


Patents Pending

Patent pending Patent pending date Investigators
1. U.S. Patent Application Serial No. 11/412,149 – Use of allogenic or syngenic major histocompatibility complex (MHC) molecules as universal adjuvants for vaccines against neoplastic disease, infection and autoimmune disease June, 2012
2. U.S. Provisional patent Application Serial No. PCT/US10/45952, Modification of recombinant adenovirus with immunogenic plasmodium circumsporozoite protein epitopes June, 2012
3. U.S. Provisional patent Application Serial No. PCT/US09/54212, Novel Adenovirus Vectors June, 2012
4. European Patent Application Serial No. 05 857215.7 - Glycolipids and analogues thereof as antigens for NKT cells June, 2012
5. U.S. Provisional Patent Application Serial No. 60/802,739 – C-glycolipids with enhanced Th1-profile June, 2012
6. U.S. Patent No. 7,771,726 – Use of synthetic glycolipids as universal adjuvants for vaccines against cancer, infectious diseases and autoimmune diseases. August, 2010 Tsuji et al.
7. U.S. Patent No. 7,534,434 - Glycolipids and analogues thereof as antigens for NK T cells May, 2009 Tsuji et al.
8. U.S. Patent No. 7,488,491 - Use of glycosylceramide as adjuvants for vaccines against infections and cancer February, 2009 Tsuji et al.
9. U.S. Patent No. 7,273,852 – Synthetic C-glycolipid and its use for treating cancer, infectious diseases and autoimmune diseases September, 2007 Tsuji et al.


4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.